Carrier characteristics influence the kinetics of passive drug loading into lipid nanoemulsions

被引:10
|
作者
Goeke, Katrin
Bunjes, Heike [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Technol, Mendelssohnstr 1, D-38106 Braunschweig, Germany
关键词
Lipid nanoparticles; Formulation; Poorly soluble drug; Diffusion coefficient; Noyes-Whitney equation; Surface area; WATER-SOLUBLE DRUGS; NANOPARTICLES; DISSOLUTION; SOLUBILITY; DIFFUSION; DELIVERY; PARTICLES; MODELS; SIZE;
D O I
10.1016/j.ejpb.2017.08.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Passive loading as a novel screening approach is a material-saving tool for the efficient selection of a suitable colloidal lipid carrier system for poorly water soluble drug candidates. This method comprises incubation of preformed carrier systems with drug powder and subsequent determination of the resulting drug load of the carrier particles after removal of excess drug. For reliable routine use and to obtain meaningful loading results, information on the kinetics of the process is required. Passive loading proceeds via a dissolution-diffusion-based mechanism, where drug surface area and drug water solubility are key parameters for fast passive loading. While the influence of the drug characteristics is mostly understood, the influence of the carrier characteristics remains unknown. The aim of this study was to examine how the lipid nanocarriers' characteristics, Le. the type of lipid, the lipid content and the particle size, influence the kinetics of passive loading. Fenofibrate was used as model drug and the loading progress was analyzed by UV spectroscopy. The saturation solubility in the nanocarrier particles, i.e. the lipid type, did not influence the passive loading rate constant. Low lipid content in the nanocarrier and a small nanocarrier particle size both increased passive loading speed. Both variations increase the diffusivity of the nanocarrier particles, which is the primary cause for fast loading at these conditions: The quicker the carrier particles diffuse, the higher is the speed of passive loading. The influence of the diffusivity of the lipid nanocarriers and the effect of drug dissolution rate were included in an overall mechanistic model developed for similar processes (A. Balakrishnan, B.D. Rege, G.L. Amidon, J.E. Polli, Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity, J. Pharm. Sci. 93 (2004) 2064-2075). The resulting mechanistic model gave a good estimate of the speed of passive loading in nanoemulsions. Whilst the drug's characteristics - apart from drug surface area - are basically fixed, the lipid nano carriers can be customized to improve passive loading speed, e.g. by using small nanocarrier particles. The knowledge of the loading mechanism now allows the use of passive loading for the straightforward, material saving selection of suitable lipid drug nanocarriers.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 50 条
  • [31] Iron oxide nanoparticles served as the primary carrier to increase drug loading in macrophages
    Zhao, Kai
    Ruan, Li
    Liu, Xuexue
    Wu, Lin
    Cao, Jin
    Shen, Song
    BIOMEDICAL MATERIALS, 2023, 18 (01)
  • [32] Influences of trehalose-modification of solid lipid nanoparticles on drug loading
    Wen, Zhen
    Lin, Jing
    Su, Junqing
    Zheng, ZongKun
    Chen, Qing
    Chen, Lidi
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2017, 119 (09)
  • [33] Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization capacity and release kinetics
    Soltys, Marek
    Zuza, David
    Boleslavska, Tereza
    Akhlasova, Sarah Machac
    Balouch, Martin
    Kovacik, Pavel
    Beranek, Josef
    Skalko-Basnet, Natasa
    Flaten, Goril Eide
    Stepanek, Frantisek
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 607
  • [34] Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery
    Zoubari, Gaith
    Staufenbiel, Sven
    Volz, Pierre
    Alexiev, Ulrike
    Bodmeier, Roland
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 110 : 39 - 46
  • [35] Study on the influence of technological factors on drug loading of poorly water-soluble drug on MCM-41 mesoporous carrier
    Popova, Teodora
    Voycheva, Christina
    Tzankov, Borislav
    PHARMACIA, 2020, 67 (04) : 351 - 356
  • [36] Insight into the Loading Properties of Na+ Green-Functionalized Clinoptilolite as a Potential Carrier for the 5-Fluorouracil Drug, its Release Kinetics, and Cytotoxicity
    Sayed, Mohamed Adel
    El-Zeiny, Hayam M.
    Khim, Jong Seong
    Ajarem, Jamaan S.
    Allam, Ahmed A.
    Abukhadra, Mostafa R.
    ACS OMEGA, 2022, 7 (08): : 6991 - 7001
  • [37] Nanostructured Lipid Carrier Containing CNS Acting Drug: Formulation, Optimization and Evaluation
    Alam, M. Intakhab
    Baboota, Sanjula
    Ahuja, Alka
    Ali, Mushir
    Ali, Javed
    Sahni, Jasjeet Kaur
    CURRENT NANOSCIENCE, 2011, 7 (06) : 1014 - 1027
  • [38] Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability
    Miriyala, Nikhila
    Ouyang, Defang
    Perrie, Yvonne
    Lowry, Deborah
    Kirby, Daniel J.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 115 : 197 - 205
  • [39] Ribogreen Fluorescent Assay Kinetics to Measure Ribonucleic Acid Loading into Lipid Nanoparticle Carriers
    Bizmark, Navid
    Nayagam, Satya
    Kim, Bumjun
    Amelemah, David F.
    Zhang, Dawei
    Datta, Sujit S.
    Priestley, Rodney D.
    Colace, Tom
    Wang, Jane
    Prud'homme, Robert K.
    ADVANCED MATERIALS INTERFACES, 2024, 11 (17)
  • [40] Drug loading to lipid-based cationic nanoparticles
    Cavalcanti, LP
    Konovalov, O
    Torriani, IL
    Haas, H
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 2005, 238 (1-4) : 290 - 293